Lexeo Therapeutics
LXEO
LXEO
59 hedge funds and large institutions have $426M invested in Lexeo Therapeutics in 2024 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 27 increasing their positions, 13 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
6.06% less ownership
Funds ownership: 86.69% → 80.63% (-6.1%)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
59
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$20.5M | |
| 2 | +$13M | |
| 3 | +$10.7M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$9.99M |
| 5 |
Verition Fund Management
Greenwich,
Connecticut
|
+$5.78M |
Top Sellers
| 1 | -$8.92M | |
| 2 | -$3.18M | |
| 3 | -$3.01M | |
| 4 |
CU
Cornell University
New York
|
-$1.98M |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$1.75M |